Real Time PCR Market to Grow with a CAGR of 4.56% through 2030F

Rising incidences of genetic disorders and rising demand for personalized medicines is expected to drive the Global Real Time PCR Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Real Time PCR Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Real Time PCR Market stood at USD 4.33 billion in 2024 and is anticipated to grow with a CAGR of 4.56% in the forecast period, 2026-2030. The market growth is being driven by an increase in the incidence of infectious diseases and genetic disorders.

This is further fueled by the rise in the number of diagnostic centers and hospitals, which are catering to the growing demand for healthcare services. Moreover, there is a notable surge in public-private investments aimed at raising awareness about illness diagnostics. The introduction of technologically sophisticated products is playing a significant role in propelling the Global Real-Time PCR market forward.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Real Time PCR Market”

The key drivers of growth are anticipated to be the increased prevalence of target diseases and rapid technological advancements, such as high-performance development and advanced qPCR systems. According to the World Health Organization (WHO), cancer was among the leading causes of death globally in 2018, accounting for 9.6 million deaths. In 2017, WHO reported that 36.9 million people were affected by HIV infection. Infectious diseases were also identified as one of the primary causes of death worldwide in 2016. The incidence of these diseases is projected to rise, positioning them as potential market leaders.PCR manufacturers are actively striving to develop novel systems and kits for molecular testing. For instance, in January 2019, QIAGEN N.V. announced its plans to launch next generation dPCR systems by 2020, which are expected to offer highly automated workflows and faster turnaround times compared to current digital PCR platforms. This technological advancement is likely to provide a significant competitive advantage for the company.

The broad range of applications is expected to drive the adoption of qPCR technologies across various scientific disciplines. These technologies find extensive use in both basic and diagnostic research, including human genetic testing, forensic research, pathogen detection, and testing for infectious diseases. The market is also anticipated to expand its application in areas such as food microbiology and the veterinary industry.The increasing incidence of genetic disorders and major infectious diseases, growing utilization of biomarker profiling for disease diagnostics, and successful implementation of the Human Genome Project are the primary factors driving the demand for technologically advanced PCR tests in the forecast period. Substantial technological breakthroughs, increased investments, funding, and grants are expected to further boost the demand for real PCR in various applications.

The Global Real-Time PCR Market is predicted to be driven by an upsurge in the incidence of infectious diseases and genetic disorders, as well as an increase in the number of diagnostic centers and hospitals. The use of genomic analysis tools in diagnosing major infectious diseases (such as HIV, TB, malaria, and hepatitis) and genetic abnormalities, including cancer, has witnessed significant growth over the past decade. The rising global prevalence of target diseases, combined with the proven efficacy of qPCR in diagnosing and estimating disease-causing microorganisms, will propel the adoption of clinical diagnostic tests (including qPCR and dPCR analysis) and drive market expansion.

The expansion of healthcare infrastructure, increased healthcare expenditures, and reduced procedural costs for qPCR-based illness diagnostics are all contributing to the progress of these markets. The growing healthcare infrastructure in emerging countries is accompanied by rapid advancements in healthcare facilities, leading to increased demand for clinical diagnostic procedures in diagnostic laboratories and higher sales of clinical qPCR and dPCR products. The public-private investments to raise awareness about illness diagnostics and the introduction of technologically sophisticated products are propelling the Global Real-Time PCR Market forward.

The Global Real Time PCR Market is segmented into product, application, end user, regional distribution, and company.

Based on end user, hospitals and diagnostic centers dominate among the listed end users. This is primarily due to the widespread adoption of qPCR for clinical diagnostics, particularly in detecting infectious diseases, genetic disorders, and cancer biomarkers. Hospitals and diagnostic labs require rapid, sensitive, and accurate testing platforms, and real-time PCR fits these needs exceptionally well, offering quick turnaround times for patient management. The COVID-19 pandemic further accelerated the deployment of qPCR across hospital networks worldwide, reinforcing its central role in clinical diagnostics. Moreover, increasing demand for personalized medicine and point-of-care molecular testing in hospitals continues to drive market share. While pharmaceutical and biotechnology companies, CROs, and research institutions use qPCR extensively for drug development and scientific research, their demand is more specialized. Forensic labs represent a smaller niche. Hence, the consistent, high-volume testing needs in hospitals and diagnostics centers make them the largest and most dominant segment globally.

Based on region, the Asia Pacific region, on the other hand, emerges as the most lucrative market, driven by notable advancements in PCR technology integration by countries like China and Japan. These advancements have significantly improved the accuracy and efficiency of diagnostic tests, leading to better patient outcomes. The emerging economies such as India and Australia have witnessed remarkable growth in healthcare, research and development (R&D), and clinical development frameworks. This not only strengthens the overall healthcare infrastructure but also creates a conducive environment for the adoption of advanced diagnostic technologies. Collectively, these factors position the Asia Pacific market to experience substantial growth opportunities throughout the forecast period.

Major companies operating in Global Real Time PCR Market are:

·         Thermo Fisher Scientific, Inc.

·         Bio-Rad Laboratories, Inc.

·         F. Hoffman-La Roche Ltd.

·         Abbott Laboratories Inc.

·         Agilent Technologies, Inc.

·         Becton Dickinson and Company

·         Enzo Life Sciences, Inc.

·         Promega Corporation

·         Biomérieux S.A.

·         Cole-Parmer Instrument Company Llc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The real-time PCR market is growing due to its expanding use in clinical diagnostics, rising demand for personalized medicine, and ongoing technological advancements. Its role in drug development and molecular biology has become increasingly vital, supporting breakthroughs in drug discovery, forensic science, and clinical R\&D. Real-time PCR is essential for developing assays, test kits, and culture media. Its widespread adoption in disease diagnosis further fuels market expansion, as healthcare systems prioritize accurate, rapid testing methods. These combined factors underscore real-time PCR’s importance across pharmaceutical, biotechnology, and life science sectors, driving consistent growth and innovation in the global market” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Real Time PCR Market Segmented By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, Research, Forensic), By End-User (Hospitals and Diagnostic Centers, Pharmaceutical, CROs and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories), By Region and Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Global Real Time PCR Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Real Time PCR Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com